IL15 and neoplasm: Concurrently, adenosine levels rise during tumor hypoxia, impairing NK cell metabolism by inhibiting both oxidative phosphorylation (OXPHOS) and glycolysis, and thereby undermining the metabolic pathways activated by IL-12 and IL-15 (115).